• Health Care M&A Deals, February 19, 2021

    The Health Care M&A deals chart is a selection of transactions announced during the prior week(s). The M&A transactions presented here are from our HealthCareMandA.com Deal Database, which is updated daily to provide our subscribers with the most up-to-date information and trends in the healthcare industry. The largest deal... Read More »
  • MindMed Acquires HealthMode

    MindMed (OTCQB: MMEDF), a New York City-based biotechnology company, is expanding its platform with a new deal. Last week, the company announced it is acquiring HealthMode, a digital medicine and therapeutics startup that uses artificial intelligence-enabled digital measurement to increase the precision and speed of clinical research and patient... Read More »
  • Humacyte Goes Public Via SPAC

    Humacyte, Inc. announced last week it is merging with Alpha Healthcare Acquisition Corp. (NASDAQ: AHAC), a special purpose acquisition company (SPAC). Shareholders of Humacyte will get an aggregate of 80 million shares of AHAC’s common stock, or roughly $800 million. Humacyte is a clinical-stage biotechnology platform company developing... Read More »
  • Charter Health Care Adds Two Omaha Agencies

    Charter Health Care Group, a portfolio company of Pharos Capital Group, announced a deal for two agencies in Omaha, Nebraska last week. It purchased Physmed Home Health Care and Serene Care Hospice, two sister companies, for an undisclosed sum. Physmed Home Health Care was founded in 2003 and specializes in geriatric care, providing physical... Read More »
  • Charles River Laboratories Acquires Cognate BioServices

    Charles River Laboratories International, Inc. (NYSE: CRL) is significantly boosting its capabilities with a new acquisition. The research giant is buying Cognate BioServices, Inc. from EW Healthcare Partners for $875 million. The acquisition and associated fees are expected to be financed through Charles River’s existing credit facility and... Read More »
Health Care M&A Deals, February 19, 2021

Health Care M&A Deals, February 19, 2021

The Health Care M&A deals chart is a selection of transactions announced during the prior week(s). The M&A transactions presented here are from our HealthCareMandA.com Deal Database, which is updated daily to provide our subscribers with the most up-to-date information and trends in the healthcare industry. The largest deal of the week by disclosed price is Charles River Laboratories International, Inc.’s acquisition of Cognate BioServices, Inc. from EW Healthcare Partners for $875 million. Cognate BioServices is a cell and gene therapy contract development and manufacturing organization (CDMO). Cognate has extensive experience producing various cell types and... Read More »
Health Care M&A Deals, February 19, 2021

Health Care M&A Deals, February 12, 2021

The Health Care M&A deals chart is a selection of transactions announced during the prior week(s). The M&A transactions presented here are from our HealthCareMandA.com Deal Database, which is updated daily to provide our subscribers with the most up-to-date information and trends in the healthcare industry. The largest deal of the week by disclosed price is Sharecare, Inc.’s reverse merger with Falcon Capital Acquisition Corp., a special purpose acquisition company, valued at $3.9 billion.  Sharecare provides an online health and wellness engagement platform that gives consumers a personal results-oriented experience by connecting them to health resources... Read More »
Health Care M&A Deals, February 19, 2021

Health Care M&A Deals, February 5, 2021

The Health Care M&A deals chart is a selection of transactions announced during the prior week(s). The M&A transactions presented here are from our HealthCareMandA.com Deal Database, which is updated daily to provide our subscribers with the most up-to-date information and trends in the healthcare industry. The largest deal of the week by disclosed price is Jazz Pharmaceuticals plc’s acquisition of GW Pharmaceuticals plc for for $7.2 billion. GW Pharmaceuticals is a global pharmaceutical company that discovers, develops, manufactures and commercializes novel, regulatory approved therapeutics from its proprietary cannabinoid product platform to address a broad range of... Read More »
Healthcare Services Bankruptcies Spiked in 2020

Healthcare Services Bankruptcies Spiked in 2020

Even before the Covid-19 pandemic arrived in the United States early in 2020, observers expected the flow of healthcare services bankruptcies filings by small rural hospitals and other service organizations stressed by regulatory and reimbursement challenges to continue at a steady trickle. Once the economic and social shutdowns began in mid-March, hospitals were forced to suspend elective procedures, emergency room visits plummeted, physician practices largely closed temporarily and home health agencies experienced a wave of visit cancellations. The cost of personal protective equipment, a requirement for healthcare workers, soared to astronomical highs. Of course, merger and acquisition... Read More »
Health Care M&A Deals, February 19, 2021

Health Care M&A Deals, January 29, 2021

The Health Care M&A deals chart is a selection of transactions announced during the prior week(s). The M&A transactions presented here are from our HealthCareMandA.com Deal Database, which is updated daily to provide our subscribers with the most up-to-date information and trends in the healthcare industry. The largest deal of the week by disclosed price is Cofinimmo’s acquisition of a portfolio of six care homes and one post-acute/rehab center in Ireland with 491 beds for $112.9 million. Six of the seven sites are located within the province of Leinster, including five within the Greater Dublin region. The final site of Castlemanor is in the province of... Read More »
Health Care M&A Deals, February 19, 2021

Health Care M&A Deals, January 22, 2021

The Health Care M&A deals chart is a selection of transactions announced during the prior week(s). The M&A transactions presented here are from our HealthCareMandA.com Deal Database, which is updated daily to provide our subscribers with the most up-to-date information and trends in the healthcare industry. The largest deal of last week was Boston Scientific Corporation’s acquisition of Preventice Solutions, Inc. for $925 million. Preventice Solutions offers a full portfolio of mobile cardiac health solutions and services, ranging from ambulatory cardiac monitors to cardiac event monitors and mobile cardiac telemetry. The company recorded net sales of $158 million in 2020, a... Read More »